Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Locations section added listing participating sites by state (e.g., Alabama, Arizona, California, District of Columbia, Florida, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Ohio, Oklahoma, Tennessee, Texas, Virginia, Washington). The page revision updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T21:16:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    A note clarifying that PubMed publications are automatically filled and may not be about the study; revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:28:37.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The government funding notice was removed from the page. It does not affect the study details, eligibility criteria, or participation instructions.
    Difference
    0.3%
    Check dated 2025-11-18T06:50:34.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Study Details page for NCT02657889 shows no significant changes between screenshots; core information about the TOPACIO trial appears unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T20:49:51.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operation status notice; removed the v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:15:48.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Added v3.1.0 and removed the Ovarian cancer resource; older v3.0.2 revision reference was present. Overall, versioning and resource scope changed.
    Difference
    0.3%
    Check dated 2025-09-29T02:59:53.000Z thumbnail image

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.